Newsroom · Sioux Falls

Medicare Part D Drug Formulary Tiers in Sioux Falls 2026: How Your Drug's Tier Decides What You Pay

The premium is the price of admission — your formulary tier is what the ride actually costs.

Big Sioux Benefits Data Desk

Published July 11, 2026 · 10 min read · Sourced from CMS.gov

When beneficiaries compare Medicare drug plans, most focus on the monthly premium. That's the wrong first number. The premium buys you access to the plan — but what you actually pay at the pharmacy each month is determined almost entirely by which tier your specific medications land on. A $0-premium plan with your heart medication on Tier 4 can cost far more per year than a $52-premium plan where the same drug sits on Tier 2.

Every number in this article is drawn from public federal data — the CMS PY2026 plan landscape, CMS 2026 star ratings, CMS Part D program rules, and CDC PLACES 2023 county health data. No numbers are invented; if we can't source a claim, it's not here.

What a Medicare drug formulary is — and why tiers matter

A formulary is a Part D plan's official list of covered drugs. Every plan is required to maintain one, publish it annually, and make it searchable. But the formulary isn't just a yes/no list — it assigns every covered drug to a cost tier that determines your out-of-pocket exposure at the pharmacy counter.

CMS sets the framework; plans fill it in. The standard five-tier structure looks like this:

Source: CMS Medicare.gov — Drug Plan Coverage Rules. Exact copay amounts vary by plan; see your plan's Evidence of Coverage.

The most consequential split is Tier 1–2 vs. Tier 3–5. Generic drugs on Tier 1 or 2 typically have the lowest copays — and in most plans, the annual deductible is waived entirely for those tiers. That means a beneficiary whose prescriptions are all common generics (think lisinopril for blood pressure, metformin for diabetes) may never touch the deductible at all. A beneficiary whose physician prefers a brand-name medication for the same condition pays the deductible first, then a higher per-fill cost.

How the deductible interacts with your tier in Sioux Falls' 5 local plans

Every standard Medicare Advantage PPO in Minnehaha County bundles Part D drug coverage. Their 2026 drug deductibles range from $300 to $615 — and the plan with the lower deductible may or may not be the better deal, depending entirely on which tier your specific drugs land on.

Source: CMS Medicare Advantage / Part D Landscape (PY2026) & CMS Medicare Advantage & Part D Star Ratings (2026), Minnehaha County 2026.

Notice the spread: Align ChoiceElite and Blue Medicare Advantage Enhanced both cap their deductible at $300 — $315 less than the two Aetna plans at $615. For a beneficiary whose drugs all fall on Tier 1–2 generics, that difference may be irrelevant (no deductible applies to those tiers in most plans). For a beneficiary on a brand-name Tier 3 drug, that $315 difference is real money in the first months of the year before the deductible is satisfied.

The practical step: before choosing based on deductible alone, look up each of your drugs on that plan's formulary and check the tier. If all your medications are Tier 1–2, both the $300 and $615 deductible plans may cost you the same — and the premium becomes the primary comparison point. If you take a Tier 3–4 drug, the lower deductible plan becomes meaningfully cheaper early in the year.

The $2,100 Part D cap: your 2026 backstop — but tiers still matter

The most important change in Medicare drug coverage in a generation arrived in 2026: a hard $2,100 annual out-of-pocket cap on Part D drug spending. Once your total qualifying out-of-pocket drug costs hit that ceiling, the plan pays 100% for the rest of the calendar year.

The cap is the safety net for beneficiaries on expensive specialty drugs — say, a cancer drug or a biologic for rheumatoid arthritis on Tier 5. Those drugs can run thousands of dollars per fill, and before 2026, there was no ceiling on what you could owe. Now there is.

But tiers still decide how fast you reach the cap. A beneficiary on all Tier 1–2 generics may spend less than $500 all year in drug cost-sharing and never come close to $2,100. A beneficiary on a Tier 5 specialty biologic could hit the cap in the first quarter. The cap protects the second group dramatically; the first group's real savings come from choosing a plan where their generics land on lower tiers.

This is why the $2,100 cap makes formulary tier selection more important, not less. The cap sets the ceiling; the tier sets the floor. You want both.

Why Minnehaha County's health profile makes this personal

Formulary tiers are not abstract for Sioux Falls' 39,532 Medicare beneficiaries. CDC data shows a county where chronic conditions — and the prescriptions that manage them — are a daily reality for a large share of the population:

Source: CDC PLACES: Local Data for Better Health, County 2023 (2023), adults in Minnehaha County.

Consider what these numbers mean for prescriptions:

• 31.7% hypertension — ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers. Most have low-cost generics on Tier 1–2; the question is whether your specific drug (and dose) has a generic equivalent on your plan's formulary.
• 10% diabetes — metformin is typically Tier 1; newer GLP-1 drugs (semaglutide, tirzepatide) commonly land on Tier 4–5. The gap in tier between an older and newer diabetes drug can mean hundreds of dollars per year in cost-sharing.
• 22.9% arthritis — ibuprofen and naproxen are generic Tier 1; biologics like adalimumab (Humira) are Tier 5 specialty. Checking the tier before you choose a plan can reveal whether a preferred formulary placement is available on another plan.
• 22.3% depression — SSRIs and SNRIs are widely generic and typically Tier 1–2; newer antidepressants may be Tier 3–4. Antidepressants are also a CMS-protected class (see below), giving you stronger coverage rights.
• 5.6% COPD — rescue inhalers have generics but brand-name inhalers are still common on Tier 3–4. Formulary choice matters significantly here.

Insulin: the $35 monthly cap that applies regardless of tier

For the 10% of Minnehaha County adults with diabetes, federal law creates one flat rule that overrides the tier system: since January 2023, the Inflation Reduction Act caps Medicare Part D cost-sharing for covered insulin products at $35 per month's supply, in all plans, regardless of tier, deductible, or plan premium. You pay $35 maximum per monthly supply of a covered insulin, period.

This matters for plan comparison: insulin cost-sharing is no longer a differentiator between plans for beneficiaries whose primary drug concern is insulin. All five Sioux Falls PPOs are equally good on insulin cost under the federal $35 cap.

What the $35 cap does not cover: other diabetes medications. GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide), SGLT-2 inhibitors, DPP-4 inhibitors — these are covered at their formulary tier with standard cost-sharing. For a diabetic patient on both insulin and a GLP-1 drug, the insulin is protected at $35/month, but the GLP-1's tier placement becomes the critical formulary question.

The six CMS-protected drug classes

Beyond insulin, CMS requires every Part D plan to cover "all or substantially all" drugs in six designated protected classes — meaning your plan can't simply drop your medication to a non-formulary tier as a cost-control measure in these categories:

Source: CMS Part D formulary and coverage rules.

If you take a drug in one of these classes, you have stronger formulary protections. Plans must cover at least two options per class, cannot require non-medical switching, and face strict limits on prior authorization and step therapy for protected-class drugs. For the 22.3% of Minnehaha County adults with depression and the approximately 2% with serious mental illness, antidepressant and antipsychotic coverage protections matter directly.

IRMAA and your Part D premium: an income-based layer on top

Higher-income beneficiaries pay an Income-Related Monthly Adjustment Amount (IRMAA) surcharge on top of their Part D plan premium. This applies to the plan premium, not the tier copays — but it's a cost that compounds when choosing between plans at different premium levels. The 2025-schedule IRMAA surcharges for Part D (based on 2023 income) are:

Source: Social Security Administration — Medicare Premiums: Rules for Higher-Income Beneficiaries (2025 schedule; verify current year at SSA.gov).

At the top IRMAA tier, a beneficiary paying a $52/month Aetna premium effectively pays $52 + $85.80 = $137.80/month for their drug coverage. That changes the premium comparison significantly — and makes the tier analysis (are my drugs on lower tiers in this plan?) even more important to justify the premium.

How to check your formulary before October 15

The 2026 Annual Enrollment Period opens October 15. Every plan publishes its new formulary and any changes by October 1 in an Annual Notice of Change (ANOC) mailed to current enrollees. Here's a repeatable process for reviewing your drug coverage before AEP:

1. List every prescription drug you take — the generic name, brand name, dose, and quantity per fill.
2. Go to Medicare.gov's Plan Finder (or use the live tool below) — enter your ZIP code and your drug list. The finder shows each plan's formulary tier for your specific drugs and your estimated annual cost at that tier.
3. Compare total annual drug cost, not just tier — the finder calculates a projected annual cost across plans. Sometimes a plan with a higher premium places your drug on Tier 2 and costs less overall than a $0-premium plan where it lands on Tier 3.
4. Check for prior authorization or step therapy requirements — some plans require you to try a lower-cost drug first (step therapy) or get advance approval (prior authorization) before they'll cover certain Tier 3–5 drugs at the plan rate. The Plan Finder flags these.
5. Note any Tier 5 specialty drugs — if you take a specialty biologic or cancer drug, check whether the plan offers a specialty pharmacy and what its cost-sharing looks like approaching the $2,100 cap.
6. Review your ANOC in September — if your current plan moved one of your drugs to a higher tier, AEP is your window to switch without penalty.

What to watch for at 2026 AEP (October 15–December 7)

1. Formulary changes in your ANOC — if a drug moved tiers, calculate the new annual impact before AEP closes December 7.
2. New generic approvals mid-year — if a brand-name drug on Tier 4 got a new generic between now and October, the new formulary may list the generic on Tier 1 at dramatically lower cost.
3. GLP-1 drug formulary placement — with growing use of semaglutide and tirzepatide for diabetes and weight management, expect plans to shift tier placement and prior-auth requirements in 2027 filings. Check for any changes affecting your current plan.
4. Plan premium and deductible changes — the AEP is when plan economics reset. A plan that was competitive in 2026 may raise its deductible or shift a drug to a higher tier for 2027.
5. Low-Income Subsidy / Extra Help eligibility — if your income is near 150% of the federal poverty level, check whether you qualify for Extra Help, which eliminates the Part D deductible and reduces cost-sharing for all tiers. Applications are accepted year-round.

How we know all this: Big Sioux Benefits runs every article through a data desk that cross-references the CMS plan landscape, county enrollment, 2026 star ratings, Part D program rules, and CDC PLACES county health data — built by Strategic AI Architects. All figures here come from public federal datasets or federal statute. This is education, not advice; confirm your plan, drug coverage, and eligibility with a licensed agent or Medicare.gov. We take no payment from any carrier to feature a plan.